See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot4,012▼ 0.30%WTI103.27▲ 3.82%
← MEMS page
XStocksXray
Market X-Ray report · 23 October 2026

Memscap Regpt (MEMS)

Euronext Paris · France · prices in EUR · close of 23 Oct 2026

Key indicators

Last closeEUR 4.510
52-week range3.565 – 6.600
Return, 1 month / 3 months−12.6% / −3.8%
Return, 1 year / 3 years+8.6% / +16.1%
TrendBelow its 200-day average
RSI (14)36
Volatility (1 year)53.9%
Worst drawdown (1 year)-28.3%
Average daily value traded0.05M EUR
Dividend yield1.5%

Market X-Ray price-based

51/ 100 · High confidence · ahead of 50% of stocks on this exchange
Trend60
Momentum61
Stability (higher is calmer)49
Liquidity55
Income6

Five-year price chart navy: price · brown: 200-day average

0.362.845.317.7810.262021-112023-022024-052025-082026-10

About the company

Memscap designs and makes micro-electro-mechanical systems, known as MEMS, for demanding applications. Its products include pressure sensors and optical components used in aerospace, medical devices and telecommunications equipment. Customers are mainly industrial and technology companies that need precise, reliable miniature sensing and optical parts. The company is based in France and serves markets around the world.

On this site Memscap Regpt appears as a stock on the Euronext Paris (France), code MEMS, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Memscap Regpt (MEMS) trades on the Euronext Paris in France. It last closed at EUR 4.510 on 23 October 2026.

Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 316 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 8.6% and over the last three months it fell 3.8%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Memscap Regpt (MEMS)

The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris

Lens and metricValueScoreReading
Trend60 · FairMixed trend against its averages.
Above 200-day average-7.1%
From 52-week high-29.1%
Momentum61 · FairTypical recent returns for this exchange.
3-month return-3.8%
6-month return-18.2%
12-month return, skipping the last month24.3%
Stability (higher is calmer)49 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)53.9%
Worst drawdown, 1 year (smaller is calmer)-28.3%
Liquidity55 · FairModerate trading activity.
Average daily value traded0.05M EUR
Zero-volume days0.0%
Income6 · WeakDividend is small or irregular.
Dividend yield1.5%
Years with dividends1

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.
  • Income: Dividend is small or irregular.

Returns

1 week−1.0%
1 month−12.6%
3 months−3.8%
6 months−18.2%
1 year+8.6%
3 years+16.1%
5 years+187.8%

Signals

50-day / 200-day average4.920 / 4.856
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceYes
Average daily range (ATR)0.151

Technical summary

DailyStrongly bearish1 bullish · 3 neutral · 12 bearish
WeeklyStrongly bearish1 bullish · 1 neutral · 10 bearish
MonthlyNeutral4 bullish · 1 neutral · 3 bearish

Recent dividends

Ex-dividend dateAmount per share
10 Jun 2026EUR 0.0660

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 24 Oct 2026